002584 Xilong Scientific
- 8.05
- -0.25-3.01%
Xilong Scientific News
Xilong Science: Report for the third quarter of 2024
xilong scientific (002584.SZ) released its performance for the first three quarters, with a net income of 64.1861 million yuan, a year-on-year increase of 117.61%.
xilong scientific (002584.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...
xilong scientific (002584.SZ): The net income in the first three quarters was 64.1861 million yuan, a year-on-year increase of 117.61%.
On October 29, Gelonhui announced the third quarter report of xilong scientific (002584.SZ) for 2024, with the company's revenue reaching 6.553 billion yuan in the first nine months, a year-on-year increase of 13.16%; the net income attributable to shareholders of the listed company was 64.1861 million yuan, a year-on-year increase of 117.61%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 62.7133 million yuan, a year-on-year increase of 175.37%; and the basic earnings per share was 0.11 yuan.
Express News | xilong scientific: the actual controller intends to transfer 5.98% of the company's shares by agreement.
xilong scientific (002584.SZ): Copper etching solution has been mass-produced and supplied to domestic leading panel enterprises.
xilong scientific (002584.SZ) stated on the investor interactive platform on October 11 that the company's copper etching solution has been mass-produced and supplied to leading domestic panel enterprises.
xilong scientific (002584.SZ): There have been no sales of nitrocellulose products since the beginning of this year.
gelonhui September 25|xilong scientific (002584.SZ) stated on the investor interaction platform that the company currently has the operational qualification for the above-mentioned product (nitrocellulose). The above-mentioned product has not been sold since the beginning of this year.
Xilong Scientific (002584.SZ): Subsidiary has not launched the titanium dioxide project
On September 4th, Xilong Scientific (002584.SZ) stated on the investor interactive platform that the company is mainly engaged in the research, development, production, and sales of chemical reagents, as well as the production and sales of active pharmaceutical ingredients, food additives, and cathode materials for lithium batteries. The company is also involved in some chemical raw material trading business. Its subsidiary has not yet carried out the titanium dioxide project.
Xilong Scientific: Half-year report for the year 2024.
Xilong Scientific: Summary of Half-Year Report in 2024.
Express News | 10 photoresist listed companies disclosed their half-year performance forecast, and xilong scientific's net profit in Q2 is expected to increase more than four times compared to the previous quarter.
Express News | xilong scientific established a new materials company with nonferrous metals casting business.
Xilong Scientific: 2024 Interim Performance Forecast
Express News | After trading hours, over 80 listed companies released announcements of expected increase or profit in their semi-annual performance. Among them, Shandong Lubei Chemical showed the highest expected increase of about 1091% YoY.
Express News | Xilong Scientific: expected net income to increase by 155%-258% year-on-year in the first half of the year.
Xilong Scientific (002584.SZ): net income in the first half of the year is expected to increase by 154.93%-258.49%.
Xilong Scientific (002584.SZ) announced its performance forecast for the first half of 2024, with a net income attributable to shareholders of the listed company of RMB 32-45 million, an increase of 154.93%-258.49% from the same period last year; and a net income of RMB 30-40 million after deducting non-recurring gains and losses, a year-on-year increase of 378.43%-537.91%. The basic earnings per share are expected to be between RMB 0.05-0.08. The net income attributable to shareholders of the listed company in the first half of 2024 has increased compared to the same period last year.
xilong scientific (002584.SZ) 2023 equity distribution: 0.2 yuan per 10 shares.
Xilong Scientific (002584.SZ) has announced that the annual equity distribution plan for 2023 is: based on the company's current...
Xilong Scientific (002584.SZ): The cathode material for lithium batteries achieved revenue of nearly 18 million yuan in 2023.
Xilong Scientific (002584.SZ) stated on the investor interaction platform on June 26th that according to the company's disclosed report for 2023, the revenue from cathode materials for lithium batteries in 2023 was nearly 18 million yuan. Currently, the company's Yunnan Yinghe lithium iron phosphate cathode material first-phase construction project has begun small-scale production, and the company is actively carrying out new customer verification and sales promotion.
Xilong Scientific (002584.SZ): Yunnan Yinghe's first-phase construction project of lithium iron phosphate cathode material has started small-scale production.
Xilong Scientific (002584.SZ) stated on the investor interaction platform on June 17th that the company's Yunnan Yinghe lithium iron phosphate cathode material first-phase construction project has started small-scale production, and the company is actively carrying out new customer validation and sales promotion work.
Xilong Scientific (002584.SZ): The company's chemical reagent products are mainly used in industries such as semiconductors, new energy funds, electronic components, petroleum and petrochemicals, and pharmaceuticals.
Xilong Scientific (002584.SZ) stated on the investor interaction platform on June 5 that the company's chemical reagent products are mainly used in industries such as semiconductors, new energy fund, electronic components, petroleum and petrochemicals, and pharmaceuticals.
Xilong Science (002584.SZ): Treatment technology not involving nuclear contaminated water
Gelonghui, May 30丨Xilong Science (002584.SZ) said on the investor interactive platform that the company is currently not involved in treatment technology related to nuclear contaminated water.
Analysis
Price Target
No Data
No Data